Strong age dependent increase in the use of adjuvant systemic treatment for early stage breast cancer in the period 1990-2006: a population based analysis

被引：0
|
作者：
Sukef, M. P. P. [1 ]
van de Poll-Franse, L. V. [2 ]
Nieuwenhuijzen, G. A. P. [3 ]
Vreugdenhil, A. [4 ]
Herings, R. M. C. [1 ]
Coebergh, J. W. W. [2 ]
Voogd, A. C. [5 ]
机构：
[1] PHARMO Inst Drug Outcomes Res, Utrecht, Netherlands
[2] Comprehens Canc Ctr S, Eindhoven, Netherlands
[3] Catharina Hosp, Eindhoven, Netherlands
[4] Maxima Medisch Centrum, Veldhoven, Netherlands
[5] Maastricht Univ, Maastricht, Netherlands
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 07期
关键词：
D O I：
10.1016/S1359-6349(08)70569-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [41] Real world outcomes of adjuvant FECD, ddACT and ACT for the treatment of early stage breast cancer - A multicenter retrospective analysis
    LeVasseur, N.
    Veitch, Z.
    Diocee, R. M.
    Gondara, L.
    Cheung, W.
    Khan, O.
    Cossetti, R.
    Gelmon, K. A.
    King, K.
    Lupichuk, S.
    Chia, S. K.
    Tang, P.
    Simmons, C.
    CANCER RESEARCH, 2019, 79 (04)
  • [42] Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation
    McGee, Sharon
    AlZahrani, Mashari
    Stober, Carol
    Ng, Terry L.
    Cole, Katherine
    Larocque, Gail
    Awan, Arif
    Sehdev, Sandeep
    Hilton, John
    Vandermeer, Lisa
    Hutton, Brian
    Pond, Gregory
    Saunders, Deanna
    Clemons, Mark
    JOURNAL OF BONE ONCOLOGY, 2021, 27
  • [43] Deescalating Adjuvant Trastuzumab in HER2-Positive Early-Stage Breast Cancer: A Systemic Review and Meta-Analysis
    Goldvaser, Hadar
    Korzets, Yasmin
    Shepshelovich, Daniel
    Yerushalmi, Rinat
    Sarfaty, Michal
    Ribnikar, Domen
    Thavendiranathan, Paaladinesh
    Amir, Eitan
    JNCI CANCER SPECTRUM, 2019, 3 (02)
  • [44] Determinants of non-adherence to adjuvant endocrine treatment in early stage breast cancer patients: A Swedish population-based registry linkage study.
    Wulaningsih, Wahyu
    Garmo, Hans
    Ahlgren, Johan
    Van Hemelrijck, Mieke
    Lambe, Mats
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [45] Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain study
    Gomez-Acebo, Ines
    Dierssen-Sotos, Trinidad
    Mirones, Monica
    Perez-Gomez, Beatriz
    Guevara, Marcela
    Amiano, Pilar
    Sala, Maria
    Molina, Antonio J.
    Alonso-Molero, Jessica
    Moreno, Victor
    Suarez-Calleja, Claudia
    Molina-Barcelo, Ana
    Alguacil, Juan
    Marcos-Gragera, Rafael
    Fernandez-Ortiz, Maria
    Sanz-Guadarrama, Oscar
    Castano-Vinyals, Gemma
    Gil-Majuelo, Leire
    Moreno-Iribas, Conchi
    Aragones, Nuria
    Kogevinas, Manolis
    Pollan, Marina
    Llorca, Javier
    SCIENTIFIC REPORTS, 2021, 11 (01) : 5375
  • [46] Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain study
    Inés Gómez-Acebo
    Trinidad Dierssen-Sotos
    Mónica Mirones
    Beatriz Pérez-Gómez
    Marcela Guevara
    Pilar Amiano
    Maria Sala
    Antonio J. Molina
    Jéssica Alonso-Molero
    Victor Moreno
    Claudia Suarez-Calleja
    Ana Molina-Barceló
    Juan Alguacil
    Rafael Marcos-Gragera
    María Fernández-Ortiz
    Oscar Sanz-Guadarrama
    Gemma Castaño-Vinyals
    Leire Gil-Majuelo
    Conchi Moreno-Iribas
    Nuria Aragonés
    Manolis Kogevinas
    Marina Pollán
    Javier Llorca
    Scientific Reports, 11
  • [47] USE OF PHARMACOGENETIC TESTING TO DETERMINE ADJUVANT HORMONAL THERAPY CHOICE IN EARLY STAGE BREAST CANCER PATIENTS: A VALUE OF INFORMATION ANALYSIS
    Woods, B. S.
    Hawkins, N. S.
    VALUE IN HEALTH, 2009, 12 (03) : A4 - A4
  • [48] The use of surgery in the treatment of ER plus early stage breast cancer in England: Variation by time, age and patient characteristics
    Richards, P.
    Ward, S.
    Morgan, J.
    Lagord, C.
    Reed, M.
    Collins, K.
    Wyld, L.
    EJSO, 2016, 42 (04): : 489 - 496
  • [49] Computer-based risk prediction models: Ethical issues of Adjuvant! Online use in early-stage breast cancer
    Kempf, E.
    Azria, E.
    Kempf, A.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2016, 44 (02): : 79 - 81
  • [50] Cardiotoxicity of adjuvant trastuzumab chemotherapy in women with early-stage breast cancer under 50 years of age based on analysis of Japanese insurance claims data
    Shimomura, Akihiko
    Ohtsu, Hiroshi
    Shimizu, Chikako
    Sase, Kazuhiro
    CANCER RESEARCH, 2022, 82 (04)
12345